DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,391,487 | -10.0% | 33,823 | -13.0% | 2.35% | -6.5% |
Q2 2023 | $9,328,560 | -5.5% | 38,869 | -0.8% | 2.51% | -12.0% |
Q1 2023 | $9,872,659 | -1.3% | 39,171 | +4.0% | 2.85% | -11.2% |
Q4 2022 | $10,000,760 | +4.3% | 37,679 | +1.5% | 3.21% | -8.7% |
Q3 2022 | $9,588,000 | +4.1% | 37,120 | +2.1% | 3.52% | +5.5% |
Q2 2022 | $9,213,000 | +3.5% | 36,340 | +19.8% | 3.33% | +21.7% |
Q1 2022 | $8,900,000 | -3.0% | 30,341 | +8.8% | 2.74% | -1.2% |
Q4 2021 | $9,179,000 | +11.0% | 27,899 | +2.7% | 2.77% | +2.0% |
Q3 2021 | $8,268,000 | +2.2% | 27,157 | -9.9% | 2.71% | +0.4% |
Q2 2021 | $8,091,000 | +30.4% | 30,150 | +9.3% | 2.70% | +15.6% |
Q1 2021 | $6,206,000 | +6.3% | 27,574 | +4.9% | 2.34% | +9.4% |
Q4 2020 | $5,839,000 | +3.1% | 26,287 | -0.0% | 2.14% | -11.8% |
Q3 2020 | $5,661,000 | +26.1% | 26,290 | +3.5% | 2.42% | +13.0% |
Q2 2020 | $4,490,000 | +22.5% | 25,394 | -4.1% | 2.14% | +0.1% |
Q1 2020 | $3,665,000 | -0.1% | 26,479 | +10.8% | 2.14% | +13.7% |
Q4 2019 | $3,667,000 | +6.4% | 23,890 | +0.1% | 1.88% | -3.5% |
Q3 2019 | $3,448,000 | +1.6% | 23,875 | +0.5% | 1.95% | -2.0% |
Q2 2019 | $3,394,000 | +5.9% | 23,750 | -2.2% | 1.99% | +2.5% |
Q1 2019 | $3,206,000 | +37.3% | 24,285 | +7.3% | 1.94% | +37.9% |
Q4 2018 | $2,335,000 | – | 22,640 | – | 1.41% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |